GrafTech Reports First Quarter 2023 Results
Successfully Executing Plans to Navigate the Current Market Conditions
Received Regulatory Approval to Restart Production Activities at
First Quarter 2023 Highlights
-
Net loss of
, or$7 million per share(1)$0.03 -
Adjusted EBITDA(2) of
$15 million - Sales volume of 17 thousand metric tons ("MT")
- Production volume of 16 thousand MT
-
Cash flow from operating activities of
$25 million
CEO Comments
"We are successfully executing our plans to manage the near-term challenges in the market," said
"As we proceed through 2023, we expect our sales volume levels to begin recovering in the second quarter with further improvement in the second half of the year," said
First Quarter 2023 Financial Performance
(dollars in thousands, except per share amounts) |
Q1 2023 |
Q4 2022 |
Q1 2022 |
|||||||
Net sales |
$ |
138,802 |
|
$ |
247,519 |
$ |
366,245 |
|||
Net (loss) income |
$ |
(7,369 |
) |
$ |
50,331 |
$ |
124,183 |
|||
(Loss) earnings per share(1) |
$ |
(0.03 |
) |
$ |
0.20 |
$ |
0.47 |
|||
Cash flow from operating activities |
$ |
24,798 |
|
$ |
50,023 |
$ |
146,316 |
|||
|
|
|
|
|||||||
Adjusted net (loss) income(2) |
$ |
(5,549 |
) |
$ |
44,761 |
$ |
125,920 |
|||
Adjusted (loss) earnings per share(1)(2) |
$ |
(0.02 |
) |
$ |
0.17 |
$ |
0.48 |
|||
Adjusted EBITDA(2) |
$ |
15,115 |
|
$ |
80,101 |
$ |
169,600 |
|||
Adjusted free cash flow(2) |
$ |
3,157 |
|
$ |
25,800 |
$ |
129,017 |
Net sales for the first quarter of 2023 were
Net loss for the first quarter of 2023 was
In the first quarter of 2023, cash flow from operating activities was
Operational and Commercial Update
Key operating metrics |
|||||||||
|
|
|
|
||||||
(in thousands, except percentages) |
Q1 2023 |
Q4 2022 |
Q1 2022 |
||||||
Sales volume (MT) |
16.9 |
|
27.8 |
|
43.3 |
|
|||
Production volume (MT)(4) |
15.8 |
|
29.4 |
|
46.1 |
|
|||
Total production capacity (MT)(5)(6) |
58.0 |
|
59.0 |
|
58.0 |
|
|||
Total capacity utilization(6)(7) |
27 |
% |
50 |
% |
79 |
% |
|||
Production capacity excluding |
51.0 |
|
52.0 |
|
51.0 |
|
|||
Capacity utilization excluding |
31 |
% |
57 |
% |
90 |
% |
Sales volume for the first quarter of 2023 was 16.9 thousand MT, consisting of 7.4 thousand MT of LTA volume and 9.5 thousand MT of non-LTA volume, and decreased
For the first quarter of 2023, the weighted-average realized price for our LTA volume was
Production volume was 15.8 thousand MT in the first quarter of 2023, a decrease of
The table of estimated shipments of graphite electrodes under existing LTAs has been updated as follows to reflect our current expectations for the full years of 2023 and 2024:
|
|
2023 |
|
2024 |
Estimated LTA volume (in thousands of MT) |
|
27 - 31 |
|
13 - 16 |
Estimated LTA revenue (in millions) |
|
|
|
|
Capital Structure and Capital Allocation
As of
Outlook
The suspension of our operations in
For the full year of 2023, we continue to expect a significant year-over-year increase in our cash cost of goods sold per MT as fixed costs are being recognized over a smaller volume base and reflecting the full-year impact of higher raw material costs that increased throughout 2022. In response to higher input costs, we are closely managing our operating costs and capital expenditures, as well as our working capital levels.
Looking ahead, we remain confident in our ability to overcome near-term challenges and are optimistic about the longer-term outlook for our business. We anticipate the steel industry’s accelerating efforts to decarbonize will lead to increased adoption of the electric arc furnace method of steelmaking, driving long-term demand growth for graphite electrodes. We also anticipate the demand for petroleum needle coke, the key raw material we use to produce our graphite electrodes, to accelerate driven by its use to produce synthetic graphite for use in lithium-ion batteries for the growing electric vehicle market. We believe that the actions we are taking, supported by a distinct set of capabilities, including our vertical integration into petroleum needle coke production via our Seadrift facility, will optimally position
Conference Call Information
In connection with this earnings release, you are invited to listen to our earnings call being held on
About
________________________ |
||
(1) |
(Loss) earnings per share represents diluted (loss) earnings per share. Adjusted (loss) earnings per share represents diluted adjusted (loss) earnings per share. |
|
(2) |
A non-GAAP financial measure, see below for more information and reconciliations to the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in |
|
(3) |
A non-GAAP financial measure, adjusted EBITDA margin is calculated as adjusted EBITDA divided by net sales (Q1 2023 adjusted EBITDA of |
|
(4) |
Production volume reflects graphite electrodes we produced during the period. |
|
(5) |
Production capacity reflects expected maximum production volume during the period depending on product mix and expected maintenance outage. Actual production may vary. |
|
(6) |
Includes graphite electrode facilities in Calais, |
|
(7) |
Capacity utilization reflects production volume as a percentage of production capacity. |
|
(8) |
Our |
|
(9) |
Includes expected termination fees from a few customers that have failed to meet certain obligations under their LTAs. |
|
(10) |
Gross debt reflects the notional value of our debt and excludes unamortized debt discount and issuance costs. |
|
(11) |
A non-GAAP financial measure, net debt is calculated as gross debt minus cash and cash equivalents. |
Cautionary Note Regarding Forward-Looking Statements
This press release and related discussions may contain forward-looking statements within the meaning of the safe harbor provisions of the
These factors should not be construed as exhaustive and should be read in conjunction with the Risk Factors and other cautionary statements that are included in our most recent Annual Report on Form 10-K and other filings with the
If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. You should specifically consider the factors identified in this press release that could cause actual results to differ before making an investment decision to purchase our common stock. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.
Non-GAAP Financial Measures
In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net (loss) income, adjusted (loss) earnings per share, free cash flow, adjusted free cash flow and net debt are non-GAAP financial measures.
We define EBITDA, a non‑GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA as EBITDA adjusted by any pension and other post-employment benefit ("OPEB") plan expenses or benefits, non‑cash gains or losses from foreign currency remeasurement of non-operating assets and liabilities in our foreign subsidiaries where the functional currency is the
We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. Adjusted EBITDA margin is also a non-GAAP financial measure used by our management and our Board of Directors as supplemental information to assess the Company’s operational performance and is calculated as adjusted EBITDA divided by net sales. In addition, we believe adjusted EBITDA, adjusted EBITDA margin and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities. We also monitor the ratio of debt to trailing twelve month adjusted EBITDA, because we believe it is a useful and widely used way to assess our leverage.
Our use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
- adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
- adjusted EBITDA does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
- adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us;
- adjusted EBITDA does not reflect expenses or benefits relating to our pension and OPEB plans;
-
adjusted EBITDA does not reflect the non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the
U.S. dollar; - adjusted EBITDA does not reflect stock-based compensation expense;
- adjusted EBITDA does not reflect the non‑cash write‑off of fixed assets;
- adjusted EBITDA does not reflect related party payable - Tax Receivable Agreement adjustments; and
- other companies, including companies in our industry, may calculate EBITDA, adjusted EBITDA and adjusted EBITDA margin differently, which reduces its usefulness as a comparative measure.
We define adjusted net (loss) income, a non‑GAAP financial measure, as net income or loss, excluding the items used to calculate adjusted EBITDA, less the tax effect of those adjustments. We define adjusted (loss) earnings per share, a non‑GAAP financial measure, as adjusted net (loss) income divided by the weighted average diluted common shares outstanding during the period. We believe adjusted net (loss) income and adjusted (loss) earnings per share are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.
Free cash flow and adjusted free cash flow, non-GAAP financial measures, are metrics used by our management and our Board of Directors to analyze cash flows generated from operations. We define free cash flow as net cash provided by operating activities less capital expenditures. We define adjusted free cash flow as free cash flow adjusted by payments of the Change in Control charges that were triggered as a result of the ownership of our largest stockholder falling below
We define net debt as gross debt (the most directly comparable GAAP measure) minus cash and cash equivalents. We believe this is an important measure as it is more representative of our financial position.
In evaluating EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net (loss) income, adjusted (loss) earnings per share, free cash flow and adjusted free cash flow, you should be aware that in the future, we will incur expenses similar to the adjustments in the reconciliations presented below. Our presentations of EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net (loss) income, adjusted (loss) earnings per share, free cash flow and adjusted free cash flow should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net (loss) income, adjusted (loss) earnings per share, free cash flow and adjusted free cash flow alongside other measures of financial performance and liquidity, including our net (loss) income, (loss) earnings per share and cash flow from operating activities, respectively, and other GAAP measures.
CONDENSED CONSOLIDATED BALANCE SHEETS (Dollars in thousands, except per share data) (Unaudited) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
135,440 |
|
|
$ |
134,641 |
|
Accounts and notes receivable, net of allowance for doubtful accounts of
|
|
83,913 |
|
|
|
145,574 |
|
Inventories |
|
468,609 |
|
|
|
447,741 |
|
Prepaid expenses and other current assets |
|
72,683 |
|
|
|
87,272 |
|
Total current assets |
|
760,645 |
|
|
|
815,228 |
|
Property, plant and equipment |
|
890,253 |
|
|
|
869,168 |
|
Less: accumulated depreciation |
|
363,154 |
|
|
|
350,022 |
|
Net property, plant and equipment |
|
527,099 |
|
|
|
519,146 |
|
Deferred income taxes |
|
17,973 |
|
|
|
11,960 |
|
|
|
171,117 |
|
|
|
171,117 |
|
Other assets |
|
78,419 |
|
|
|
86,727 |
|
Total assets |
$ |
1,555,253 |
|
|
$ |
1,604,178 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
86,645 |
|
|
$ |
103,156 |
|
Long-term debt, current maturities |
|
128 |
|
|
|
124 |
|
Accrued income and other taxes |
|
12,142 |
|
|
|
40,592 |
|
Other accrued liabilities |
|
94,113 |
|
|
|
89,349 |
|
Related party payable - Tax Receivable Agreement |
|
5,137 |
|
|
|
4,631 |
|
Total current liabilities |
|
198,165 |
|
|
|
237,852 |
|
|
|
|
|
||||
Long-term debt |
|
922,500 |
|
|
|
921,803 |
|
Other long-term obligations |
|
51,613 |
|
|
|
50,822 |
|
Deferred income taxes |
|
46,698 |
|
|
|
45,065 |
|
Related party payable - Tax Receivable Agreement long-term |
|
5,784 |
|
|
|
10,921 |
|
Stockholders’ equity: |
|
|
|
||||
Preferred stock, par value |
|
— |
|
|
|
— |
|
Common stock, par value |
|
2,567 |
|
|
|
2,566 |
|
Additional paid-in capital |
|
745,891 |
|
|
|
745,164 |
|
Accumulated other comprehensive loss |
|
(6,024 |
) |
|
|
(8,070 |
) |
Accumulated deficit |
|
(411,941 |
) |
|
|
(401,945 |
) |
Total stockholders’ equity |
|
330,493 |
|
|
|
337,715 |
|
|
|
|
|
||||
Total liabilities and stockholders’ equity |
$ |
1,555,253 |
|
|
$ |
1,604,178 |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Dollars in thousands, except per share data) (Unaudited) |
|||||||
|
Three Months
Ended |
||||||
|
2023 |
|
2022 |
||||
|
|
|
|
||||
Net sales |
$ |
138,802 |
|
|
$ |
366,245 |
|
Cost of goods sold |
|
112,645 |
|
|
|
191,214 |
|
Gross profit |
|
26,157 |
|
|
|
175,031 |
|
Research and development |
|
1,192 |
|
|
|
880 |
|
Selling and administrative expenses |
|
22,151 |
|
|
|
21,254 |
|
Operating income |
|
2,814 |
|
|
|
152,897 |
|
|
|
|
|
||||
Other expense (income), net |
|
653 |
|
|
|
(197 |
) |
Interest expense |
|
12,806 |
|
|
|
9,212 |
|
Interest income |
|
(372 |
) |
|
|
(98 |
) |
(Loss) income before (benefit) provision for income taxes |
|
(10,273 |
) |
|
|
143,980 |
|
(Benefit) provision for income taxes |
|
(2,904 |
) |
|
|
19,797 |
|
Net (loss) income |
$ |
(7,369 |
) |
|
$ |
124,183 |
|
|
|
|
|
||||
Basic (loss) income per common share: |
|
|
|
||||
Net (loss) income per share |
$ |
(0.03 |
) |
|
$ |
0.47 |
|
Weighted average common shares outstanding |
|
256,974,904 |
|
|
|
262,592,029 |
|
Diluted (loss) income per common share: |
|
|
|
||||
Net (loss) income per share |
$ |
(0.03 |
) |
|
$ |
0.47 |
|
Weighted average common shares outstanding |
|
256,974,904 |
|
|
|
262,657,799 |
|
|
|
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Dollars in thousands) (Unaudited) |
|||||||
|
Three Months
Ended |
||||||
|
2023 |
|
2022 |
||||
Cash flow from operating activities: |
|
|
|
||||
Net (loss) income |
$ |
(7,369 |
) |
|
$ |
124,183 |
|
Adjustments to reconcile net (loss) income to cash provided by operations: |
|
|
|
||||
Depreciation and amortization |
|
10,777 |
|
|
|
14,434 |
|
Deferred income tax (benefit) provision |
|
(3,750 |
) |
|
|
1,395 |
|
Non-cash stock-based compensation expense |
|
796 |
|
|
|
465 |
|
Non-cash interest expense |
|
2,184 |
|
|
|
(2,146 |
) |
Other adjustments |
|
105 |
|
|
|
403 |
|
Net change in working capital* |
|
25,657 |
|
|
|
12,590 |
|
Change in related party Tax Receivable Agreement |
|
(4,631 |
) |
|
|
(3,828 |
) |
Change in long-term assets and liabilities |
|
1,029 |
|
|
|
(1,180 |
) |
Net cash provided by operating activities |
|
24,798 |
|
|
|
146,316 |
|
Cash flow from investing activities: |
|
|
|
||||
Capital expenditures |
|
(25,271 |
) |
|
|
(16,855 |
) |
Proceeds from the sale of fixed assets |
|
92 |
|
|
|
73 |
|
Net cash used in investing activities |
|
(25,179 |
) |
|
|
(16,782 |
) |
Cash flow from financing activities: |
|
|
|
||||
Interest rate swap settlements |
|
3,630 |
|
|
|
(887 |
) |
Debt issuance and modification costs |
|
(128 |
) |
|
|
— |
|
Principal payments on long-term debt |
|
— |
|
|
|
(70,000 |
) |
Repurchase of common stock |
|
— |
|
|
|
(30,000 |
) |
Payments for taxes related to net share settlement of equity awards |
|
(129 |
) |
|
|
(230 |
) |
Proceeds from exercise of stock options |
|
— |
|
|
|
225 |
|
Dividends paid to non-related party |
|
(1,926 |
) |
|
|
(1,985 |
) |
Dividends paid to related party |
|
(640 |
) |
|
|
(640 |
) |
Net cash provided by (used in) financing activities |
|
807 |
|
|
|
(103,517 |
) |
Net change in cash and cash equivalents |
|
426 |
|
|
|
26,017 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
373 |
|
|
|
1,522 |
|
Cash and cash equivalents at beginning of period |
|
134,641 |
|
|
|
57,514 |
|
Cash and cash equivalents at end of period |
$ |
135,440 |
|
|
$ |
85,053 |
|
|
|
|
|
||||
* Net change in working capital due to changes in the following components: |
|
|
|||||
Accounts and notes receivable, net |
$ |
62,350 |
|
|
$ |
(1,221 |
) |
Inventories |
|
(16,897 |
) |
|
|
(24,215 |
) |
Prepaid expenses and other current assets |
|
12,588 |
|
|
|
(5,298 |
) |
Income taxes payable |
|
(25,594 |
) |
|
|
(19,419 |
) |
Accounts payable and accruals |
|
(12,495 |
) |
|
|
56,958 |
|
Interest payable |
|
5,705 |
|
|
|
5,785 |
|
Net change in working capital |
$ |
25,657 |
|
|
$ |
12,590 |
|
NON-GAAP RECONCILIATIONS (Dollars in thousands, except per share data) (Unaudited) |
||||||||||||
The following tables reconcile our non-GAAP key financial measures to the most directly comparable GAAP measures: |
||||||||||||
Reconciliation of Net (Loss) Income to Adjusted Net (Loss) Income |
|
|
|
|||||||||
|
Q1 2023 |
Q4 2022 |
Q1 2022 |
|||||||||
|
|
|
|
|||||||||
Net (loss) income |
$ |
(7,369 |
) |
$ |
50,331 |
|
$ |
124,183 |
|
|||
|
|
|
|
|||||||||
Diluted (loss) income per common share: |
|
|
|
|||||||||
Net (loss) income per share |
$ |
(0.03 |
) |
$ |
0.20 |
|
$ |
0.47 |
|
|||
Weighted average shares outstanding |
|
256,974,904 |
|
|
256,902,385 |
|
|
262,657,799 |
|
|||
|
|
|
|
|||||||||
Adjustments, pre-tax: |
|
|
|
|||||||||
Pension and OPEB plan expenses (benefits)(1) |
|
918 |
|
|
(8,993 |
) |
|
551 |
|
|||
Non-cash losses on foreign currency remeasurement(2) |
|
447 |
|
|
819 |
|
|
1,236 |
|
|||
Stock-based compensation expense(3) |
|
796 |
|
|
645 |
|
|
465 |
|
|||
Non-cash fixed asset write-off (4) |
|
— |
|
|
1,068 |
|
|
— |
|
|||
Related party payable - Tax Receivable Agreement adjustment(5) |
|
16 |
|
|
97 |
|
|
(180 |
) |
|||
Total non-GAAP adjustments pre-tax |
|
2,177 |
|
|
(6,364 |
) |
|
2,072 |
|
|||
Income tax impact on non-GAAP adjustments(6) |
|
357 |
|
|
(794 |
) |
|
335 |
|
|||
Adjusted net (loss) income |
$ |
(5,549 |
) |
$ |
44,761 |
|
$ |
125,920 |
|
Reconciliation of (Loss) Earnings Per Share to Adjusted (Loss) Earnings Per Share |
|||||||||||
|
|
|
|
||||||||
|
Q1 2023 |
Q4 2022 |
Q1 2022 |
||||||||
|
|
|
|
||||||||
(Loss) earnings per share |
$ |
(0.03 |
) |
$ |
0.20 |
|
$ |
0.47 |
|||
Adjustments per share: |
|
|
|
||||||||
Pension and OPEB plan expenses (benefits)(1) |
|
0.01 |
|
|
(0.04 |
) |
|
— |
|||
Non-cash losses on foreign currency remeasurement(2) |
|
— |
|
|
— |
|
|
0.01 |
|||
Stock-based compensation expense(3) |
|
— |
|
|
— |
|
|
— |
|||
Non-cash fixed asset write-off (4) |
|
— |
|
|
0.01 |
|
|
— |
|||
Related party payable - Tax Receivable Agreement adjustment(5) |
|
— |
|
|
— |
|
|
— |
|||
Total non-GAAP adjustments pre-tax per share |
|
0.01 |
|
|
(0.03 |
) |
|
0.01 |
|||
Income tax impact on non-GAAP adjustments per share(6) |
|
— |
|
|
— |
|
|
— |
|||
Adjusted (loss) earnings per share |
$ |
(0.02 |
) |
$ |
0.17 |
|
$ |
0.48 |
Reconciliation of Net (Loss) Income to Adjusted EBITDA |
|
|||||||||||
|
|
|
|
|||||||||
|
Q1 2023 |
Q4 2022 |
Q1 2022 |
|||||||||
|
|
|
|
|||||||||
Net (loss) income |
$ |
(7,369 |
) |
$ |
50,331 |
|
$ |
124,183 |
|
|||
Add: |
|
|
|
|||||||||
Depreciation and amortization |
|
10,777 |
|
|
13,788 |
|
|
14,434 |
|
|||
Interest expense |
|
12,806 |
|
|
11,533 |
|
|
9,212 |
|
|||
Interest income |
|
(372 |
) |
|
(2,283 |
) |
|
(98 |
) |
|||
Income taxes |
|
(2,904 |
) |
|
13,096 |
|
|
19,797 |
|
|||
EBITDA |
|
12,938 |
|
|
86,465 |
|
|
167,528 |
|
|||
Adjustments: |
|
|
|
|||||||||
Pension and OPEB plan expenses (benefits)(1) |
|
918 |
|
|
(8,993 |
) |
|
551 |
|
|||
Non-cash losses on foreign currency remeasurement(2) |
|
447 |
|
|
819 |
|
|
1,236 |
|
|||
Stock-based compensation expense(3) |
|
796 |
|
|
645 |
|
|
465 |
|
|||
Non-cash fixed asset write-off (4) |
|
— |
|
|
1,068 |
|
|
— |
|
|||
Related party payable - Tax Receivable Agreement adjustment(5) |
|
16 |
|
|
97 |
|
|
(180 |
) |
|||
Adjusted EBITDA |
$ |
15,115 |
|
$ |
80,101 |
|
$ |
169,600 |
|
|||
|
|
|
|
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow and Adjusted Free Cash Flow |
||||||||||||
|
|
|
|
|||||||||
|
Q1 2023 |
Q4 2022 |
Q1 2022 |
|||||||||
|
|
|
|
|||||||||
Net cash provided by operating activities |
$ |
24,798 |
|
$ |
50,023 |
|
$ |
146,316 |
|
|||
Capital expenditures |
|
(25,271 |
) |
|
(26,884 |
) |
|
(16,855 |
) |
|||
Free cash flow |
|
(473 |
) |
|
23,139 |
|
|
129,461 |
|
|||
|
|
|
|
|||||||||
Interest rate swap settlements(7) |
|
3,630 |
|
|
2,661 |
|
|
(887 |
) |
|||
Change in Control payment(8) |
|
— |
|
|
— |
|
|
443 |
|
|||
Adjusted free cash flow |
$ |
3,157 |
|
$ |
25,800 |
|
$ |
129,017 |
|
(1) |
Net periodic benefit cost (credit) for our pension and OPEB plans, including a mark-to-market (gain) loss, representing actuarial gains and losses that result from the remeasurement of plan assets and obligations due to changes in assumptions or experience. We recognize in earnings the actuarial gains and losses in connection with the annual remeasurement in the fourth quarter of each year. |
|
(2) |
Non-cash losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(3) |
Non-cash expense for stock-based compensation grants. |
|
(4) |
Non-cash write-off of fixed assets. |
|
(5) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
|
(6) |
The tax impact on the non-GAAP adjustments is affected by their tax deductibility and the applicable jurisdictional tax rates. |
|
(7) |
Receipt (payment) of cash related to the monthly settlement of our outstanding interest rate swap contracts. |
|
(8) |
In the second quarter of 2021, we incurred pre-tax Change in Control charges of |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230427005707/en/
216-676-2000
investor.relations@graftech.com
Source: